These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32093010)

  • 1. A CRISPR Test for Rapidly and Sensitively Detecting Circulating EGFR Mutations.
    Tsou JH; Leng Q; Jiang F
    Diagnostics (Basel); 2020 Feb; 10(2):. PubMed ID: 32093010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive Detection of KRAS Mutations by Clustered Regularly Interspaced Short Palindromic Repeats.
    Zhou H; Tsou JH; Leng Q; Jiang F
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33467412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
    Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR
    JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer.
    Kim B; Kim Y; Shin S; Lee ST; Cho JY; Lee KA
    Cancer Cell Int; 2022 Feb; 22(1):82. PubMed ID: 35168603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantification of
    Silveira C; Sousa AC; Janeiro A; Malveiro S; Teixeira E; Brysch E; Pantarotto M; Felizardo M; Madureira R; Nogueira F; Guimarães C; Matos C; Canário D; Bruges-Armas J; Carmo-Fonseca M
    Transl Lung Cancer Res; 2021 Mar; 10(3):1200-1208. PubMed ID: 33889502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of EGFR mutations in NSCLC with highly sensitive droplet digital PCR assays.
    Jiang XW; Liu W; Zhu XY; Xu XX
    Mol Med Rep; 2019 Jul; 20(1):593-603. PubMed ID: 31115577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer.
    Suryavanshi M; Mehta A; Panigrahi MK; Jaipuria J; Saifi M; Jain K; Kumar D; Verma H; Sharma SK; Batra U; Dutta K; Talwar V; Doval DC
    Lung India; 2018; 35(5):384-389. PubMed ID: 30168456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction.
    Xu Q; Zhu Y; Bai Y; Wei X; Zheng X; Mao M; Zheng G
    Onco Targets Ther; 2015; 8():1533-41. PubMed ID: 26124670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of plasma EGFR mutations in patients with lung cancers: Comparison of the performance of ARMS-Plus and droplet digital PCR.
    Wang L; Guo Q; Yu W; Qiao L; Zhao M; Zhang C; Hu X; Yang G; Xiong L; Lou J
    Lung Cancer; 2017 Dec; 114():31-37. PubMed ID: 29173762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CRISPR Test for Detection of Circulating Nuclei Acids.
    Tsou JH; Leng Q; Jiang F
    Transl Oncol; 2019 Dec; 12(12):1566-1573. PubMed ID: 31634698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC.
    Zhu YJ; Zhang HB; Liu YH; Zhu YZ; Chen J; Li Y; Bai JP; Liu LR; Qu YC; Qu X; Chen X; Zheng GJ
    Oncol Lett; 2017 Aug; 14(2):2573-2579. PubMed ID: 28789464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients.
    Hackner K; Buder A; Hochmair MJ; Strieder M; Grech C; Fabikan H; Burghuber OC; Errhalt P; Filipits M
    Clin Med Insights Oncol; 2021; 15():1179554921993072. PubMed ID: 33642890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.
    Suzawa K; Yamamoto H; Ohashi K; Hashida S; Tomida S; Kubo T; Maki Y; Soh J; Tsukuda K; Kiura K; Miyoshi S; Toyooka S
    Oncol Rep; 2017 May; 37(5):3100-3106. PubMed ID: 28405680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
    Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
    Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.
    Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W
    Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Platform Comparison of Four Leading Technologies for Detecting
    Xu T; Kang X; You X; Dai L; Tian D; Yan W; Yang Y; Xiong H; Liang Z; Zhao GQ; Lin S; Chen KN; Xu G
    Theranostics; 2017; 7(6):1437-1446. PubMed ID: 28529628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.
    Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y
    Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.
    Zhang S; Chen Z; Huang C; Ding C; Li C; Chen J; Zhao J; Miao L
    Analyst; 2019 Feb; 144(5):1718-1724. PubMed ID: 30663747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy.
    Kim Y; Shin S; Lee KA
    Cancer Cell Int; 2021 Jan; 21(1):50. PubMed ID: 33435996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR.
    Watanabe M; Kawaguchi T; Isa SI; Ando M; Tamiya A; Kubo A; Saka H; Takeo S; Adachi H; Tagawa T; Kawashima O; Yamashita M; Kataoka K; Ichinose Y; Takeuchi Y; Watanabe K; Matsumura A; Koh Y
    EBioMedicine; 2017 Jul; 21():86-93. PubMed ID: 28625519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.